0.4948

1.04% -0.0052

VolitionRX Ltd (VNRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

$0.50

Aprire:

$0.481

Volume 24 ore:

266.96K

Relative Volume:

1.51

Capitalizzazione di mercato:

$50.40M

Reddito:

$1.29M

Utile/perdita netta:

$-29.87M

Rapporto P/E:

-1.3744

EPS:

-0.36

Flusso di cassa netto:

$-14.70M

1 W Prestazione:

-1.06%

1M Prestazione:

+1.39%

6M Prestazione:

-33.85%

1 anno Prestazione:

-40.31%

Intervallo 1D:

$0.48

$0.5166

Intervallo di 1 settimana:

$0.48

$0.537

Portata 52W:

$0.42

$0.90

VolitionRX Ltd Stock (VNRX) Company Profile

Nome

VolitionRX Ltd

Settore

Healthcare (1154)

Industria

Diagnostics & Research (56)

Telefono

646 650 1351

Indirizzo

No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX

Dipendente

Cinguettio

@VolitionRx

Prossima data di guadagno

2025-03-31

Ultimi documenti SEC

VNRX's Discussions on Twitter

Confronta VNRX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VNRX VolitionRX Ltd	0.4948	50.40M	1.29M	-29.87M	-14.70M	-0.36
TMO Thermo Fisher Scientific Inc	432.59	159.40B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	200.83	141.27B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	509.53	38.21B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	115.55	30.90B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	156.13	26.35B	15.50B	1.33B	2.16B	7.34

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-04-08	Iniziato	H.C. Wainwright	Buy
2023-02-01	Downgrade	The Benchmark Company	Buy → Hold
2022-02-17	Ripresa	Cantor Fitzgerald	Overweight
2021-03-10	Iniziato	Cantor Fitzgerald	Overweight
2018-05-16	Iniziato	Maxim Group	Buy
2018-05-14	Reiterato	The Benchmark Company	Buy
2016-09-07	Reiterato	Rodman & Renshaw	Buy
2016-02-01	Iniziato	Rodman & Renshaw	Buy

Mostra tutto

VolitionRX Ltd Borsa (VNRX) Ultime notizie

May 10, 2025

VolitionRx (VNRX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025

May 07, 2025

VolitionRx Updates Progress Of Nu.Q NETs Test Adoption - marketscreener.com

May 07, 2025

StockNews.com Begins Coverage on VolitionRx (NYSE:VNRX) - Defense World

May 07, 2025

Apr 29, 2025

VolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Apr 29, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 23, 2025

VolitionRx enters new sales agreement, terminates old one - Investing.com Australia

Apr 23, 2025

Apr 22, 2025

VolitionRx enters new sales agreement, terminates old one By Investing.com - Investing.com South Africa

Apr 22, 2025

Apr 18, 2025

VolitionRX Ltd (AMEX: VNRX): An Enticing Stock To Watch - stocksregister.com

Apr 18, 2025

Insider Buying: Reynolds Cameron John, VolitionRX Ltd [VNRX] President and CEO invested 181,818 shares - knoxdaily.com

Apr 18, 2025

Apr 14, 2025

VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - The AM Reporter

Apr 14, 2025

Apr 11, 2025

H.C. Wainwright maintains buy on VolitionRX with $2.50 target By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 10, 2025

VolitionRX stock holds as Benchmark maintains rating By Investing.com - Investing.com South Africa

Apr 08, 2025

This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Apr 08, 2025

HC Wainwright Initiates VolitionRx With Buy Rating, $2.50 Price Target - marketscreener.com

Apr 08, 2025

Apr 05, 2025

VolitionRx (NYSE:VNRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 05, 2025

Apr 04, 2025

VolitionRx Moves to Register Warrant Shares on New Form By Investing.com - Investing.com South Africa

Apr 04, 2025

VolitionRx Moves to Register Warrant Shares on New Form - Investing.com

Apr 04, 2025

Apr 02, 2025

VolitionRx Limited (AMEX:VNRX) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 02, 2025

Apr 01, 2025

VolitionRx Ltd. Earnings Call Highlights Growth and Challenges - TipRanks

Apr 01, 2025